Torthaí cuardaigh - Huitema, Alwin D R

Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels de réir Groenland, Stefanie L., Katz, Daniela, Huitema, Alwin D. R., Steeghs, Neeltje

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] de réir Hendrikx, Jeroen J M A, Beijnen, Jos H, Huitema, Alwin D R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components de réir Bastida, Carla, Soy, Dolors, Ruiz‐Esquide, Virginia, Sanmartí, Raimon, Huitema, Alwin D.R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis de réir Dorlo, Thomas P. C., Huitema, Alwin D. R., Beijnen, Jos H., de Vries, Peter J.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice de réir Simeoli, Raffaele, Dorlo, Thomas P. C., Hanff, Lidwien M., Huitema, Alwin D. R., Dreesen, Erwin

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses de réir Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152) de réir Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia de réir Boerlage, Thomas C. C., van Hees, Charlotte L. E., Huitema, Alwin D. R., Lauw, Fanny N.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing de réir Verheijen, Remy B., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R., Steeghs, Neeltje

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes de réir van Eijk, Maarten, Boosman, René J., Schinkel, Alfred H., Huitema, Alwin D. R., Beijnen, Jos H.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MS de réir de Jong, Karen A.M., Rosing, Hilde, Vermunt, Marit, Huitema, Alwin D.R., Beijnen, Jos H.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review de réir Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Correction to: Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review de réir Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin de réir Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′‐difluorodeoxyuridine and their nucleotides de réir Derissen, Ellen J. B., Huitema, Alwin D. R., Rosing, Hilde, Schellens, Jan H. M., Beijnen, Jos H.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model de réir ter Heine, Rob, Kane, Sean P., Huitema, Alwin D.R., Krasowski, Matthew D., van Maarseveen, Erik M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs de réir Molenaar-Kuijsten, Laura, Van Balen, Dorieke E. M., Beijnen, Jos H., Steeghs, Neeltje, Huitema, Alwin D. R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa de réir Ekhart, Corine, Doodeman, Valerie D, Rodenhuis, Sjoerd, Smits, Paul H M, Beijnen, Jos H, Huitema, Alwin D R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents de réir Zandvliet, Anthe S., Karlsson, Mats O., Schellens, Jan H. M., Copalu, William, Beijnen, Jos H., Huitema, Alwin D. R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer de réir Koolen, Stijn L W, Oostendorp, Roos L, Beijnen, Jos H, Schellens, Jan H M, Huitema, Alwin D R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán